Terms: = Lymphoma AND ENO2, HEL-S-279, NSE AND Clinical Outcome
1 results:
1. Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy.
Wang L; Liu P; Chen X; Geng Q; Lu Y
Med Oncol; 2012 Sep; 29(3):2153-8. PubMed ID: 21877195
[TBL] [Abstract] [Full Text] [Related]
